T CELL RECEPTORS TARGETING MUTATED CDKN2A
Patent Cooperation Treaty
PCT/US2023/078190
Filed on 2023-10-30
PCT/US2023/078190
Filed on 2023-10-30
METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION
Singapore
10202302822Q
Filed on 2023-10-03
10202302822Q
Filed on 2023-10-03
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
Singapore
10202302739V
Filed on 2023-09-27
10202302739V
Filed on 2023-09-27
ANTI-KRAS-G12D T CELL RECEPTORS
Australia
2023233125
Filed on 2023-09-21
2023233125
Filed on 2023-09-21
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION
European Patent
22721599.3
Filed on 2023-11-20
22721599.3
Filed on 2023-11-20
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION
US Application 18/286,911
Filed on 2023-10-13
Filed on 2023-10-13
STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES
Switzerland
19705051.1
Filed on 2019-01-30
19705051.1
Filed on 2019-01-30
STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES
United Kingdom
19705051.1
Filed on 2019-01-30
19705051.1
Filed on 2019-01-30
STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES
Germany
19705051.1
Filed on 2019-01-30
19705051.1
Filed on 2019-01-30